Question 1

What is the catalog number for Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4), PE?

Accepted Answer

The catalog number for Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4), PE is FHC09622.

Question 2

What sizes are available for Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4), PE?

Accepted Answer

Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4), PE is available in the following size(s): 100 Tests.

Question 3

Is Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4), PE in stock?

Accepted Answer

Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4), PE is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4), PE

Product Specifications

Accession Number

Reactivity

Conjugation

Applications

Stability

Endotoxin

Form

Buffer

Notes

Frequently Asked Questions

Explore Other Products

CD44 Standard (DF1485), CF680 conjugate, 0.1mg/mL

Human IgG Immunoglobulin (IG266), CF488A conjugate, 0.1mg/mL

CD104 (UM-A9), CF568 conjugate, 0.1mg/mL

Fibronectin (HFN7.1), CF647 conjugate, 0.1mg/mL

CD10 (CB-CALLA), CF680 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF543 conjugate, 0.1mg/mL